Results 171 to 180 of about 1,998,403 (289)
Research advances in Janus kinase inhibitors for immune checkpoint inhibitors-related myocarditis. [PDF]
Leng J, Wang C, Bai C.
europepmc +1 more source
A sono‐responsive chemo‐immune checkpoint nanoinhibitor (Sono‐TT8) co‐delivering TPZ chemotherapy and siXkr8 simultaneously kills tumor cells and blocks PS externalization, reversing chemotherapy‐induced immunosuppression and enhancing antitumor immunity. ABSTRACT Breast cancer features an immunosuppressive tumor microenvironment following chemotherapy
Yunfan Liu +13 more
wiley +1 more source
IMMU-NO versus yes: Applicability of immune checkpoint inhibitors in gynecologic cancers. [PDF]
Manning WB, Youssef AM, Yeku OO.
europepmc +1 more source
Pharmacology of Immune Checkpoint Inhibitors
Immune checkpoint inhibitors are a class of drugs that act on immune checkpoints (the three major ones being CTLA4, PD-1, and PD-L1) and are novel treatment options for cancer.
Panigrahi, Debi
core
Sepsis triggers hippocampal SIRT7 loss, promoting histone H2B succinylation and activation of the PD‐1/PD‐L1–PINK1 axis. This metabolic‐epigenetic cascade drives aberrant mitophagy and neuronal injury, ultimately causing cognitive deficits. Targeting SIRT7‐dependent succinylation offers a potential strategy to protect brain function during sepsis ...
Na Meng +12 more
wiley +1 more source
Multimodality imaging for the detection of cardiotoxicity in cancer patients treated with immune checkpoint inhibitors. [PDF]
Pastore MC +17 more
europepmc +1 more source
Machine‐learning‐driven transcriptomic analysis identifies FSTL3 as a key tumor‐microenvironment regulator in desmoplastic pancreatic adenocarcinoma. A cRGD‐modified liposome co‐loading gemcitabine and siFSTL3 serves as an irradiation‐triggered in situ nanovaccine. It synergizes with radiotherapy to induce ferroptosis and immunogenic cell death through
Chengyi Huang +11 more
wiley +1 more source
Turning immune checkpoint inhibitors into synthetic switches for engineered T cells. [PDF]
Li YR.
europepmc +1 more source
Interleukin‐39 is a Prognostic Biomarker and Therapy Target for Sepsis
Sepsis triggers a significant increase in IL‐39 production, with circulating levels markedly elevated and positively correlated with disease severity and poor clinical prognosis in sepsis patients. Mechanistically, macrophage‐derived IL‐39 activates the GP130 signaling pathway via a ligand‐receptor interaction, thereby fueling the pro‐inflammatory ...
Feng‐zhi Zhang +9 more
wiley +1 more source
Consensus guidance of immune checkpoint inhibitors in locally advanced rectal cancer. [PDF]
Yang Z +25 more
europepmc +1 more source

